Niagen Bioscience (NAGE) Short term Debt (2016 - 2018)

Niagen Bioscience (NAGE) has 3 years of Short term Debt data on file, last reported at $137000.0 in Q4 2018.

• Short term Debt for Q4 2018 came in at $137000.0, down 55.81% year-over-year; the trailing twelve-month figure through Dec 2018 was $137000.0 (down 55.81% YoY), and the FY2018 annual result was $137000.0, down 55.81% from the prior year.
• Short term Debt fell to $137000.0 in Q4 2018 per NAGE's latest filing, from $310000.0 in the prior quarter.
• Over five years, Short term Debt peaked at $1.5 million in Q1 2016 and troughed at $137000.0 in Q4 2018.
• A 3-year average of $579894.5 and a median of $327000.0 in 2016 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2016 and 2017: Short term Debt slumped 77.5% in 2016, then decreased 9.88% in 2017.
• A 3-year view of Short term Debt shows it stood at $344000.0 in 2016, then fell by 9.88% to $310000.0 in 2017, then slumped by 55.81% to $137000.0 in 2018.
• Business Quant data shows NAGE's Short term Debt at $137000.0 in Q4 2018, $310000.0 in Q4 2017, and $344000.0 in Q4 2016.